IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v9y2018i1d10.1038_s41467-018-06119-y.html
   My bibliography  Save this article

Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target

Author

Listed:
  • Emilio Yángüez

    (Institute of Medical Virology)

  • Annika Hunziker

    (Institute of Medical Virology)

  • Maria Pamela Dobay

    (SIB Swiss Institute of Bioinformatics)

  • Soner Yildiz

    (University of Geneva)

  • Simon Schading

    (Institute of Medical Virology)

  • Elizaveta Elshina

    (Institute of Medical Virology)

  • Umut Karakus

    (Institute of Medical Virology)

  • Peter Gehrig

    (Functional Genomics Centre Zurich)

  • Jonas Grossmann

    (Functional Genomics Centre Zurich)

  • Ronald Dijkman

    (Institute of Virology and Immunology
    University of Bern)

  • Mirco Schmolke

    (University of Geneva)

  • Silke Stertz

    (Institute of Medical Virology)

Abstract

Although annual influenza epidemics affect around 10% of the global population, current treatment options are limited and development of new antivirals is needed. Here, using quantitative phosphoproteomics, we reveal the unique phosphoproteome dynamics that occur in the host cell within minutes of influenza A virus (IAV) infection. We uncover cellular kinases required for the observed signaling pattern and find that inhibition of selected candidates, such as the G protein-coupled receptor kinase 2 (GRK2), leads to decreased IAV replication. As GRK2 has emerged as drug target in heart disease, we focus on its role in IAV infection and show that it is required for viral uncoating. Replication of seasonal and pandemic IAVs is severely decreased by specific GRK2 inhibitors in primary human airway cultures and in mice. Our study reveals the IAV-induced changes to the cellular phosphoproteome and identifies GRK2 as crucial node of the kinase network that enables IAV replication.

Suggested Citation

  • Emilio Yángüez & Annika Hunziker & Maria Pamela Dobay & Soner Yildiz & Simon Schading & Elizaveta Elshina & Umut Karakus & Peter Gehrig & Jonas Grossmann & Ronald Dijkman & Mirco Schmolke & Silke Ster, 2018. "Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target," Nature Communications, Nature, vol. 9(1), pages 1-13, December.
    • Handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-06119-y
    DOI: 10.1038/s41467-018-06119-y
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-018-06119-y
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-018-06119-y?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-06119-y. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.